CN1857441A - Preparation and application of total salvianolic acid composition - Google Patents
Preparation and application of total salvianolic acid composition Download PDFInfo
- Publication number
- CN1857441A CN1857441A CN 200610046078 CN200610046078A CN1857441A CN 1857441 A CN1857441 A CN 1857441A CN 200610046078 CN200610046078 CN 200610046078 CN 200610046078 A CN200610046078 A CN 200610046078A CN 1857441 A CN1857441 A CN 1857441A
- Authority
- CN
- China
- Prior art keywords
- total
- content
- salvianolic acid
- flavone
- flavones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to compound preparation with total salvianolic acid composition as main component for treating cardiac and cerebral vascular diseases. The total salvianolic acid composition contains total salvianolic acid in 1-99 wt%, and total haw stem and leaf phenolic acid, gingko leaf flavonid, sowthistle-leaf ixeris flavonid, safflower flavonid, total astragalus flavone and saponin, general peony glycosideor, seabuckthorn flavonid, pueraria flavonid, or total erigeron braviscapus flavone in 1-99 wt%, and is compounded with pharmaceutically acceptable supplementary material to prepare pharmaceutically acceptable preparations. The medicine of the present invention is used in preventing and treating cardiac and cerebral vascular diseases, senile dementia, and other diseases.
Description
Technical field:
The present invention relates to a kind of compound preparation of the treatment cardiovascular and cerebrovascular disease based on total salvianolic acid composition.And the application of various preparations in pharmaceutical field that utilizes the inventive method to obtain, the particularly application in the medicine of preparation control cardiovascular and cerebrovascular disease, senile dementia, cerebral infarction, cerebral ischemia and other various diseases of causing by cerebral ischemia thereof etc.Make a distinction between the important and the lesser one in the full side of medicine of the present invention, compatibility is proper, and complementation is short mutually.
Background technology:
Radix Salviae Miltiorrhizae, Fructus Crataegi, Semen Ginkgo, Herba Ixeritis Sonchifoliae, Flos Carthami, the Radix Astragali, Radix Paeoniae Rubra, the Radix Paeoniae Alba, Fructus Hippophae, Herba Erigerontis etc. all are China's conventional Chinese medicines, its medicine as the treatment cardiovascular and cerebrovascular disease has basis of clinical application widely and long clinical application history, and evident in efficacy.Modern pharmacology studies show that effects such as salvianolic acid has the myocardium shrinkage function of improvement, blood vessel dilating, brings high blood pressure down, improves coronary artery and cerebral artery blood flow amount, anticoagulant, raising cell hypoxia-bearing capability; Total phenolic acids of Caulis Crataegi and Folium Crataegi improves significantly to the blood ability of penetrating, the oxygen metabolism effect tool of heart, can significantly increase cardiac output and cardiac output, increases venous oxygen content, reduces myocardial oxygen consumption, improves the blood supply oxygen supply of cardiac muscle; Folium Ginkgo total flavones and Herba Ixeritis Sonchifoliae total flavones have effects such as blood vessel dilating, blood flow increasing, blood viscosity lowering, quickening blood flow rate, anti-hypoxia; Flos Carthami total flavone has effects such as coronary artery dilator, coronary blood flow increasing, microcirculation improvement, blood fat reducing, blood pressure lowering; Radix Astragali total flavones and total saponins thereof have the myocardium shrinkage function of improvement, dwindle myocardial infarction area, alleviate myocardial damage, improve myocardial ischemia, protect effects such as cardiovascular and cerebrovascular vessel, microcirculation improvement, antiviral property myocarditis; Peoniflorin have promote learning memory disorder due to learning and memory, the antagonism scopolamine, significantly improve learning memory disorder due to the cerebral ischemia re-pouring, improve effects such as body microcirculating state, blood viscosity lowering, the inductive platelet aggregation of inhibition ADP; Breviscapine can reduce Peripheral resistance, reduce myocardial oxygen consumption, promote collateral circulation, anticoagulant, improve cardiovascular and cerebrovascular circulation, increase effects such as cardiovascular and cerebrovascular vessel blood flow.Modern clinical research shows that Fructus Hippophae total flavones has curative effect preferably for angina pectoris, coronary heart disease.
How to overcome the shortcoming of taking single medicinal material, reasonable compatibility, short complementary mutually, make it to become effective good recipe of treatment diseases of cardiovascular and cerebrovascular systems, making it to bring into play the best use of at aspect such as improve cardio-cerebrovascular function and control aging of brain, raise immunity, slow down aging, improve the quality of living is its maximum difficult point.
Summary of the invention:
The objective of the invention is defective and deficiency at above-mentioned prior art existence, provide a kind of and can overcome the shortcoming of taking single medicinal material, reasonable compatibility, short complementary mutually, make it to become effective good recipe of treatment diseases of cardiovascular and cerebrovascular systems, make it that the best use of is brought into play in the aspect improving cardio-cerebrovascular function and control aging of brain, raise immunity, slow down aging, improve the quality of living etc.
Further aim of the present invention provides the salvianolic acid compositions (compositions of salvianolic acid and total phenolic acids of Caulis Crataegi and Folium Crataegi, the compositions of salvianolic acid and Folium Ginkgo total flavones, the compositions of salvianolic acid and Herba Ixeritis Sonchifoliae total flavones, salvianolic acid and total safflower flavone composition, salvianolic acid and Radix Astragali total flavones and total astragalin composition, the compositions of salvianolic acid and Radix Paeoniae Alba total glycosides, the compositions of salvianolic acid and Fructus Hippophae total flavones, Radix Salviae Miltiorrhizae total phenolic acids and breviscapine compositions) and the application of preparation in pharmaceutical field, particularly be used to prevent and treat cardiovascular and cerebrovascular disease in preparation, senile dementia, other dysfunction that cerebral ischemia causes, the medicine of the anti-ageing disease of waiting for a long time.
The present invention is implemented by following technical proposals.
The present invention relates to a kind of is the method for the compound preparation of main preparation control cardiovascular and cerebrovascular disease, senile dementia, cerebral ischemia and other various diseases of being caused by cerebral ischemia thereof etc. by the salvianolic acid compositions, it is characterized in that this method comprises following content:
(1) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part and total phenolic acids of Caulis Crataegi and Folium Crataegi (content of total phenolic acid is 20%～100% in the total phenolic acids of Caulis Crataegi and Folium Crataegi), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(2) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part and Folium Ginkgo total flavoness (content of total flavone is 20%～100% in the Folium Ginkgo total flavones), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(3) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part and Herba Ixeritis Sonchifoliae total flavoness (content of total flavone is 20%～100% in the Herba Ixeritis Sonchifoliae total flavones), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(4) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part of and Flos Carthami total flavones (content of total flavone is 20%～100% in the total flavones), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(5) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) (content of total flavone is 30%～90% in the Radix Astragali total flavones for 1～99 part and Radix Astragali total flavones and total saponins, the content of total saponins is 10%～90%) 99～1 parts, respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(6) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 1～99 part and Radix Paeoniae Alba total glycosides (comprise Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides, wherein the content of Radix Paeoniae Alba total glycosides is 20%～100%) 99～1 parts, respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(7) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part and Fructus Hippophae total flavoness (content of total flavone is 20%～100% in the Fructus Hippophae total flavones), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
(8) (total content of compositions such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and the total content of danshensu and salvianolic acid B is 20%～98% to get salvianolic acid respectively according to composition by weight calculating.) 99～1 parts of 1～99 part and breviscapines (content of flavone is 50%～100% in the breviscapine), respectively or mix the back and add suitable adjuvant such as antioxidant, chelating agent, filler, framework material etc. and make said various preparations on any pharmaceutics.As be used for can be made into forms such as corresponding tablet, granule, capsule when oral; Make powder pin, freeze-dried powder, transfusion etc. when being used to inject.
The specific embodiment
The following examples can help those skilled in the art more fully to understand the present invention.But do not limit the present invention in any way.
Embodiment 1 salvianolic acid Fructus Crataegi freeze-dried powder
Get salvianolic acid 2g respectively, total phenolic acids of Caulis Crataegi and Folium Crataegi 0.5g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 2 salvianolic acid Folium Ginkgo lyophilized powder pins
Get salvianolic acid 1.5g respectively, Folium Ginkgo total flavones 1.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 3 salvianolic acid Ixers sonchifolia freeze-dried powders
Get salvianolic acid 2g respectively, Herba Ixeritis Sonchifoliae total flavones 1.5g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 4 salvianolic acid Radix Paeoniae freeze-dried powders
Get salvianolic acid 1g respectively, Radix Paeoniae Alba total glycosides 2.5g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 5 salvianolic acid Flos Carthami freeze-dried powders
Get salvianolic acid 2.5g respectively, Flos Carthami total flavone 1.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 6 salvianolic acid Radix Astragali freeze-dried powders
Get salvianolic acid 2.5g respectively, Radix Astragali total flavones and total saponins 1.0g mix the back with an amount of water for injection dissolving, add 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 7 salvianolic acid Fructus Hippophae freeze-dried powders
Get salvianolic acid 2g respectively, Fructus Hippophae total flavones 1.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 8 salvianolic acid breviscapine frozen dry powders
Get salvianolic acid 2.5g respectively, breviscapine Fructus Hippophae total flavones 1.0g mixes the back with an amount of water for injection dissolving, adds 16g mannitol, after the dissolving, be diluted to 200ml, filter with water for injection, fill, lyophilizing adopts conventional injectable powder preparation method can obtain 100 freeze-dried powders.
Embodiment 9 salvianolic acid Folium Ginkgo capsule
Get salvianolic acid 20g respectively, Folium Ginkgo total flavones 15g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 10 salvianolic acid Fructus Crataegi capsules
Get salvianolic acid 15g respectively, total phenolic acids of Caulis Crataegi and Folium Crataegi 15g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 11 salvianolic acid Herba Ixeritis Sonchifoliae capsules
Get salvianolic acid 15g respectively, Herba Ixeritis Sonchifoliae total flavones 20g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 12 salvianolic acid Radix Paeoniae capsules
Get salvianolic acid 20g respectively, Radix Paeoniae Alba total glycosides 15g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 13 salvianolic acid safflower capsules
Get salvianolic acid 15g respectively, Flos Carthami total flavone 8g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 14 salvianolic acid Radix Astragali capsules
Get salvianolic acid 10g respectively, Radix Astragali total flavones and total saponins 20g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 15 salvianolic acid Fructus Hippophae capsules
Get salvianolic acid 20g respectively, Fructus Hippophae total flavones 15g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
Embodiment 16 salvianolic acid breviscapine capsules
Get salvianolic acid 25g respectively, breviscapine 15g, starch 150g adopts conventional capsule preparation method thereof can make 1000 capsules after mixing.
The extraction of embodiment 17 Herba Erigerontis total flavones, total phenolic acids of Caulis Crataegi and Folium Crataegi, Folium Ginkgo total flavones, Herba Ixeritis Sonchifoliae total flavones, Flos Carthami total flavone, Radix Puerariae total flavones, Fructus Hippophae total flavones, Radix Astragali total flavones
(1) takes by weighing Herba Erigerontis or hawthorn stem and leaf or Semen Ginkgo stem and leaf or Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or variable concentrations alcohol (comprising ethanol, methanol etc.) extract 1～3 time, and (the solvent consumption is 15Kg～30Kg), be evaporated to 0.5～1L, add 1～4L ethanol, filter, reclaim ethanol to there not being the alcohol flavor.Concentrate with suitable quantity of water dissolving (100～1000ml), with organic solvent degreasing (comprise petroleum ether, chloroform, etc., hyposynchronization also can save), extractions such as ethyl acetate or n-butyl alcohol or n-amyl alcohol, get final product behind the recovery organic solvent the total flavones crude product.
(2) take by weighing Herba Erigerontis or hawthorn stem and leaf or Semen Ginkgo stem and leaf or Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, add 6～10 times of water gagings, regulate pH to 8～9, decocted 0.5～3 hour, filter, extract so repeatedly 1～3 time with lime cream.Merge extractive liquid, is chilled to below 70 ℃, regulates pH to 3～5 with acid (comprising mineral acid and organic acid such as acetic acid, trichloroacetic acid such as hydrochloric acid, sulphuric acid), and is static, filter get final product the total flavones crude product.
(3) take by weighing Herba Erigerontis or hawthorn stem and leaf or Semen Ginkgo stem and leaf or Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or different concentration ethanol are extracted 1～3 time, and (the solvent consumption is 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filter, reclaim ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), (comprise polarity, middle polarity and nonpolar macroporous adsorption resin through the separation of macroporous adsorbent resin chromatography post, the ratio of the consumption of resin and crude drug is 1: 0.2～5), water, different concentration ethanol or methanol-eluted fractions successively, collect different concentration ethanol or methanol-eluted fractions fraction, reclaim get final product behind the solvent the different total flavones elaboration of purity.The total flavones crude product that obtains in above-mentioned (1 and 2) also can be by macroporous adsorbent resin chromatography post refining (method be the same).
(4) take by weighing Herba Erigerontis or hawthorn stem and leaf or Semen Ginkgo stem and leaf or Herba Ixeritis Sonchifoliae or Flos Carthami or Fructus Hippophae or Radix Astragali 1Kg, water or different concentration ethanol are extracted 1～3 time, and (the solvent consumption is 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filter, reclaim ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), separate through the polyamide chromatographic column, water, different concentration ethanol or methanol-eluted fractions are collected different concentration ethanol or methanol-eluted fractions fraction successively, reclaim get final product behind the solvent the different total flavones elaboration of purity.The total flavones crude product that obtains in above-mentioned (1 and 2) also can be by polyamide chromatographic column refining (method be the same).
The extraction of embodiment 18 Radix Paeoniae Alba total glycosides
(1) take by weighing Radix Paeoniae 1Kg, water or variable concentrations alcohol (comprising ethanol, methanol etc.) extract 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.Concentrate with suitable quantity of water dissolving (100～1000ml), with organic solvent degreasing (comprise petroleum ether, chloroform, ethyl acetate etc., hyposynchronization also can save), n-butanol extraction (comprising n-amyl alcohol etc.), reclaim get final product behind the n-butyl alcohol total glycosides slightly.
(2) take by weighing Radix Paeoniae 1Kg, water or different concentration ethanol are extracted 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol to there not being the alcohol flavor.With suitable quantity of water dissolving (100～1000ml), (comprise polarity, middle polarity and nonpolar macroporous adsorption resin through the separation of macroporous adsorbent resin chromatography post, the ratio of the consumption of resin and crude drug is 1: 0.2～5), water, different concentration ethanol eluting successively, collect the different concentration ethanol eluting fraction, get final product the different total glycosides elaboration of purity.The thick total saponins that obtains in above-mentioned (1) also can be by macroporous adsorbent resin chromatography post refining (method be the same).
The extraction of embodiment 19 Radix Salviae Miltiorrhizae total phenolic acidss
Take by weighing Radix Salviae Miltiorrhizae 1Kg, water or different concentration ethanol are extracted 1～3 time (the solvent consumption are 15Kg～30Kg), be evaporated to 0.5～1L, adds 1～4L ethanol, filters, and reclaims ethanol and can not get the salvianolic acid crude product to there being pure flavor.The salvianolic acid crude product is soluble in water, (comprise polarity, middle polarity and nonpolar macroporous adsorption resin with the separation of macroporous adsorbent resin chromatography post, the ratio of the consumption of resin and crude drug is 1: 0.2～5), water, different concentration ethanol eluting successively, collect different eluting fractions, can get the different salvianolic acid of purity.
Claims (9)
1, a kind of total salvianolic acid composition, it is characterized in that being grouped into (percentage by weight): Radix Salviae Miltiorrhizae total phenolic acids 1%～99%, total phenolic acids of Caulis Crataegi and Folium Crataegi 99%～1% or Folium Ginkgo total flavones 99%～1% or Herba Ixeritis Sonchifoliae total flavones and saponin 99%～1% or Flos Carthami total flavone 99%～1% or Radix Astragali total flavones and total saponins 99%～1% or Radix Paeoniae Alba total glycosides (comprising Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides) 99%～1% or Fructus Hippophae total flavones 99%～1% or Herba Erigerontis total flavones (comprising the pure product of breviscapine) 99%～1% by following one-tenth.More particularly, be meant in Radix Salviae Miltiorrhizae total phenolic acids and the said medicine combination of any one or two or more medicines, be equipped with proper pharmaceutical excipients and make the pharmaceutically various preparations of acceptable.
2, according to right 1 described preparation, it is characterized in that: Radix Salviae Miltiorrhizae total phenolic acids is the water-soluble phenolic acid compounds in the Radix Salviae Miltiorrhizae in the described composition, the content of total composition such as its total phenolic acid compound such as danshensu, protocatechualdehyde, salvianolic acid B is 30%～100%, and wherein the content sum of danshensu and salvianolic acid B is 20%～98%.
3, according to right 1 described preparation, it is characterized in that: the content of total phenolic acid is 20%～100% in the total phenolic acids of Caulis Crataegi and Folium Crataegi in the described composition; Content of total flavone is 20%～100% in the Folium Ginkgo total flavones; Content of total flavone is 20%～100% in the Herba Ixeritis Sonchifoliae total flavones; Content of total flavone is 20%～100% in the Flos Carthami total flavone; Content of total flavone is 20%～100% in the Fructus Hippophae total flavones.
4, according to right 1 described preparation, it is characterized in that: content of total flavone is 30%～90% in Radix Astragali total flavones in the described composition and the total saponins, and the content of total saponins is 10%～90%.
5, according to right 1 described preparation, it is characterized in that: the content of the Radix Paeoniae Alba total glycosides in the Radix Paeoniae Alba total glycosides in the described composition (comprising Radix Paeoniae Rubra total glycosides and Radix Paeoniae Alba total glucosides) is 20%～100%.
6, according to right 1 described preparation, it is characterized in that: the content of flavone is 50%～100% in the Herba Erigerontis total flavones in the described composition, comprises that also content reaches the breviscapine more than 90%.
7, according to right 1 described preparation of compositions method, it is characterized in that: it is the characteristics according to various compositionss, and the modern preparation technique that allows on the employing pharmaceutics is realized.
8, all kinds of preparations of making according to right 1 described compositions, it is characterized in that: it comprises injection type, peroral dosage form, percutaneous dosing dosage form, mucosa absorption dosage form.
9, all kinds of preparations of making according to right 1 described compositions is characterized in that: be mainly used in other dysfunction, the anti-ageing disease of waiting for a long time that control cardiovascular and cerebrovascular disease, senile dementia, cerebral infarction, cerebral ischemia cause.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610046078 CN1857441A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total salvianolic acid composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610046078 CN1857441A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total salvianolic acid composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1857441A true CN1857441A (en) | 2006-11-08 |
Family
ID=37296429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610046078 Pending CN1857441A (en) | 2006-03-17 | 2006-03-17 | Preparation and application of total salvianolic acid composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1857441A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101288705B (en) * | 2007-04-18 | 2010-12-22 | 北京本草天源药物研究院 | Medicine composition mainly for adjusting blood fat and its preparation method |
| CN103070943A (en) * | 2013-01-28 | 2013-05-01 | 西北农林科技大学 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| CN103099896A (en) * | 2013-01-06 | 2013-05-15 | 车艳艳 | Herb tea for treating cardiovascular and cerebrovascular diseases |
| CN108310254A (en) * | 2018-05-04 | 2018-07-24 | 青岛大学附属医院 | A kind of preparation method of cardiovascular health natural plant composition |
| CN108452201A (en) * | 2018-05-04 | 2018-08-28 | 青岛大学附属医院 | A kind of cardiovascular health natural plant composition |
-
2006
- 2006-03-17 CN CN 200610046078 patent/CN1857441A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101288705B (en) * | 2007-04-18 | 2010-12-22 | 北京本草天源药物研究院 | Medicine composition mainly for adjusting blood fat and its preparation method |
| CN103099896A (en) * | 2013-01-06 | 2013-05-15 | 车艳艳 | Herb tea for treating cardiovascular and cerebrovascular diseases |
| CN103099896B (en) * | 2013-01-06 | 2014-10-01 | 车艳艳 | Herb tea for treating cardiovascular and cerebrovascular diseases |
| CN103070943A (en) * | 2013-01-28 | 2013-05-01 | 西北农林科技大学 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| CN103070943B (en) * | 2013-01-28 | 2015-05-13 | 西北农林科技大学 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| CN108310254A (en) * | 2018-05-04 | 2018-07-24 | 青岛大学附属医院 | A kind of preparation method of cardiovascular health natural plant composition |
| CN108452201A (en) * | 2018-05-04 | 2018-08-28 | 青岛大学附属医院 | A kind of cardiovascular health natural plant composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857473A (en) | Gynostemma pentaphylla saponin composition preparation and its preparing process | |
| CN1857472A (en) | Ginsenoside composition preparation and its preparing process | |
| CN1857441A (en) | Preparation and application of total salvianolic acid composition | |
| CN1857388A (en) | Preparation and application of notoginseng stem and leaf total saponin composition | |
| CN100534508C (en) | Method for extracting effective sites group of smilax China root | |
| CN1314403C (en) | Composition of paeoniflorin and albiflorin and its preparation method | |
| CN1229324C (en) | Extraction process of tanshin general phenolic acid and its prepn and use | |
| CN1857442A (en) | Preparation and application of ligustrazine and its salt composition | |
| CN1857377A (en) | Preparation and application of total safflower flavone composition | |
| CN1771977A (en) | Notoginseng glycol-saponin composition and its prepn and use | |
| CN101036708A (en) | Medicine composition for treatment of cardio-cerebralvascular disease | |
| CN1857395A (en) | Compound Chinese medicine composition for treating cardiac and cerebral vascular diseases | |
| CN1857469A (en) | Arasaponin composition preparation and its preparing process | |
| CN1686200A (en) | Tulip poplar extract, refined extract and its application in medicine preparation | |
| CN101658542B (en) | Soft-lithospermum total phenolic acid and use thereof in pharmacy | |
| CN1911272A (en) | Powder injection contg. high content tanshin polyphenolic acid salts, and its prepn. method | |
| CN100431566C (en) | Chinese medicine composition and its prepn process and application | |
| CN1857471A (en) | Tribuloside composition preparing and its preparing process | |
| CN1857439A (en) | Preparation and application of ginkgo leaf flavonid composition | |
| CN1857470A (en) | Preparation and application of shortscape fleabane herb flavonid composition | |
| CN1857468A (en) | Prepn and application of haw heaf total phenolic acid composition | |
| CN1919254B (en) | Pharmaceutical compositions and its application | |
| CN1857387A (en) | Preparation and application of pueraria flavonid composition | |
| CN1319578C (en) | Prescription of Chinese medicine compound preparation, its preparation method and use | |
| CN1857443A (en) | Preparation and application of astragalus flavonid and total astragalin composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |